Clinical trial

Switching From an SSRI to Tiagabine(GABITRIL) in Order to Alleviate SSRI Induced…

NCT00174850 · State University of New York - Upstate Medical University, Other · Completed

Key facts

NCT number NCT00174850
Title Switching From an SSRI to Tiagabine(GABITRIL) in Order to Alleviate SSRI Induced Sexual Dysfunction
Official title A 14 Week Open-Label Study to Evaluate the Tolerability of Switching From an SSRI to Tiagabine(GABITRIL) in Order to Alleviate SSRI Induced Sexual Dysfunction in Generalized Anxiety Disorder Patients
Lead sponsor State University of New York - Upstate Medical University, Other
Status Completed
Phase Phase 4
Study type Interventional
Conditions Anxiety, Sexual Dysfunction
Intervention type Drug
Interventions Gaitril
Enrollment 30
Start date Jul 1, 2004
Completion May 1, 2005
First posted Sep 15, 2005
Last update posted Sep 18, 2008
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies